Tests a spray to reduce opioid use and pain
Part of Pain clinical trials.
This early trial studies whether Syntocinon can lower pain and help reduce how much opioids people use. It checks safety and the best dose by giving participants the study drug under close medical monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can speak and understand English well enough for study visits
- You currently use opioids recreationally
- Your current weight is within 20% of your “ideal” weight
- You have not had chronic pain (no pain on most days for the past 3 months)
- Your blood pressure, heart rate, and EKG (heart test) must be in safe ranges
- Your blood tests should not show major health problems that make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether oxytocin (a hormone-like medication) can reduce how “appealing” opioids feel and also reduce pain. It’s aimed at older adults who have used opioids before but are not currently dealing with chronic pain most days.
This study tests whether a nasal spray called oxytocin (TNX-1900) can reduce pain and help recovery after surgery for a pituitary tumor. It is for adults who are about to have pituitary surgery and are not on certain medications or with certain health conditions.
This study tests a low-dose form of buprenorphine (a medicine for pain) placed inside the cheek. It is designed for people who have never taken opioids before, to see how well it works for pain and how likely it is to be misused.
This Phase 2 study tests whether taking testosterone can lessen chronic non-cancer spinal pain in men who have low testosterone while using opioid pain medicines. It may help by improving hormone levels that could be affecting pain and overall wellbeing.
This early-stage study tests whether dronabinol (a form of THC) changes pain perception in people with opioid use disorder who are already stable on methadone or buprenorphine. It may help researchers understand whether this treatment affects pain and drug-related outcomes in a safer, controlled way.
This study tests a sleep improvement program to help people with chronic widespread pain reduce or stop their opioid pain medication. If you want to cut back on opioids and have trouble sleeping, this treatment might be a good fit.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.